AC
Abhinav Choubey
Baylor College of Medicine, Indian Institute of Technology Mandi
Research areas: Medicine · Epidemiology · Liver Disease Diagnosis and Treatment · Adipokines, Inflammation, and Metabolic Diseases · COVID-19 Clinical Research Studies
0000-0002-6025-6820
Employment
-
Baylor College of Medicine postdoctoral fellow2021 - Present
Education
- 2017 - 2021
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Intermittent AP-1 activation in muscles contributes to exercise-induced health benefits Save
- Muscle Rev-erb controls time-dependent adaptations to chronic exercise in mice. Save
- A light-responsive neural circuit suppresses feeding. Save
- Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor. Save
- LDN Protects Bone Property Deterioration at Different Hierarchical Levels in T2DM Mice Bone. Save
- Influence of low dose naltrexone on Raman assisted bone quality, skeletal advanced glycation end-products and nano-mechanical properties in type 2 diabetic mice bone. Save
- NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet Save
- Low-dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia Save
- Naltrexone a potential therapeutic candidate for COVID-19. Save
- Hyperinsulinemia promotes HMGB1 release leading to inflammation induced systemic insulin resistance: An interplay between pancreatic beta-cell and peripheral organs Save
- Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis. Save
- Novel insights into the dynamics behavior of glucagon-like peptide-1 receptor with its small molecule agonists. Save
- Small Molecule Inhibiting Nuclear Factor-kB Ameliorates Oxidative Stress and Suppresses Renal Inflammation in Early Stage of Alloxan-Induced Diabetic Nephropathy in Rat. Save